Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Introducing Juvederm Vollure® at The Choe Center
  • USA - English


News provided by

The Choe Center

Apr 12, 2017, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Kyle S. Choe, M.D., F.A.C.S.
Kyle S. Choe, M.D., F.A.C.S.

(PRWEB) April 12, 2017 -- Facial and Plastic Surgeon Dr. Kyle S. Choe at The Choe Center is one of the first practices in the Hampton Roads area of Virginia Beach, VA, to offer Vollure® by Juvederm. Allergan, who is the pharmaceutical company providing Juvéderm nonsurgical treatments, has announced that Juvéderm Vollure® XC has achieved FDA approval in the United States, and The Choe Center is excited to announce the addition of Juvederm Vollure® to their list of exceptional nonsurgical treatments.

Juvéderm Vollure® XC is approved for the treatment of deep, unwanted smile lines around the mouth and folds of the facial skin caused by aging. Juvederm products are FDA approved for facial rejuvenation and lip augmentation. The Juvederm treatment line is hugely popular at The Choe Center for Facial Plastic Surgery. In fact, Dr. Choe is one of the top Juvederm providers throughout the state of Virginia. Juvederm Vollure® is an FDA-approved treatment for moderate to severe facial wrinkles and folds.

Juvéderm Vollure® XC is a hyaluronic acid dermal filler that is FDA-approved for the treatment of nasolabial folds, which are typical signs of age around the mouth, as-well-as other facial wrinkles and folds. The filler is applicable for modern and severe folds, lines and wrinkles. Vollure® is a treatment that provides outstanding results for men and women over the age of 21 for up to 18 months.

The exciting news of the Vollure® FDA-approval was announced after a successful, clinical trial revealed very promising findings. During the trial, 59 percent of the male and female patients experienced improvement in nasolabial folds that lasted up to 18 months. The longevity of Vollure® results is a substantial finding because most facial fillers provide results that last for up to a year. The study also revealed a significant patient satisfaction percentage with 82 percent of patients reporting satisfaction after six months and 68 percent reporting satisfaction at 18 months.

Juvederm Vollure® is an outstanding, nonsurgical procedure that may be used alone or in combination with other facial and neck treatments offered by Dr. Choe at The Choe Center. Vollure® is a breakthrough facial treatment that Dr. Choe is proud to provide for patients who desire lasting results from a minimally invasive treatment. Vollure® is a next-generation HA filler designed by Allergan to meet the needs of patients. Allergan's commitment to scientific research and development is one of the factors that keeps Juvederm in the number one selling position for dermal filler products.

Juvéderm Vollure® XC utilizes the Vycross technology that is also used in Juvéderm Voluma® XC to plump the cheek area and in Juvéderm Volbella® XC to plump the lips. Juvéderm Vollure® XC is specialized and approved by the FDA for the treatment of the nasolabial folds, which are one of the most requested areas for treatment. Juvéderm injections are easy to use, have minimal to no downtime and provide outstanding, long-lasting results. The Vollure® clinical studies reveal the longest results in comparison to every other nasolabial folds treatment option.

Dr. Choe is excited to offer a product such as Juvéderm Vollure® XC, which is shown to last for up to 18 months after an initial or touch-up injection in the majority of patients. This development is major news among plastic surgical providers who routinely treat nasolabial folds with injectable fillers and who desire to offer a higher-quality filler that can provide outstanding results for a longer treatment term.

The simple, in-office procedure takes 45-minutes to an hour complete, and immediate results are experienced. The area will experience the finalized improvements within a few days after any minor swelling subsides. Patients can anticipate zero downtime and can return to their regular work and activity schedule immediately.

Juvederm Vollure® is at The Choe Center in Greater Hampton Roads!

Dr. Choe has provided patients in the greater Hampton Roads with the newest and best facial and neck treatments since he transitioned in 2004 from a well-known, plastic surgical practice in upstate New York. Dr. Choe specializes in facial reconstructive and cosmetic plastic surgery for the face and neck, and he is recognized for the exceptional, restorative results that he provides for men and women.

Dr. Choe is one of the first doctors to offer Juvéderm Vollure® XC in Virginia Beach, VA. The Choe Center is also one of the most popular and trusted surgical centers in the United States. Call (757) 389-5850 to learn more about the innovative opportunities to restore youth that is offered at The Choe Center.

The Choe Center with Dr. Kyle S. Choe
4400 Corporation Lane, Suite 102,
Virginia Beach, VA 23462

Dr. Kyle S. Choe, The Choe Center, https://www.choecenter.com, +1 (757) 389-5850, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.